Patentability Risks Posed by AI in Drug Discovery | Insights | Ropes & Gray LLP
Artificial intelligence(“AI”) can potentially address these inefficiencies by reducing costs, especially at the drug discovery and design stage. The …
Read the original at ropesgray.com ↗
- Tags
- AI Use Case
- Tracked via
- Google Alert “AI Risks”